search
Back to results

Individualized Study of Refeeding to Optimize iNpatient Gains (i-STRONG)

Primary Purpose

Atypical Anorexia Nervosa

Status
Enrolling by invitation
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Individualized Caloric Refeeding (ICR)
Higher Calorie Refeeding (HCR)
Sponsored by
University of California, San Francisco
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Atypical Anorexia Nervosa focused on measuring Malnutrition, Refeeding, Nutritional Rehabilitation, Adolescent Medicine

Eligibility Criteria

12 Years - 24 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 12-24 yrs
  • Meets Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for AAN
  • Hospitalized with medical instability, as defined by:

    1. night time heart rate (HR) <45 bpm,
    2. systolic blood pressure (SBP) <90 mmHg,
    3. temperature <35.6° C,
    4. orthostatic Δ HR >35 bpm, or
    5. orthostatic Δ SBP >20 mmHg

Exclusion Criteria:

  • Bulimia nervosa
  • Current pregnancy
  • Chronic disease (e.g. immune, renal disease)
  • Acute/active suicidality or psychosis
  • Hospital admissions for refeeding in the prior 6 mo.

Sites / Locations

  • Stanford University Lucille Packard Children's Hospital
  • University of California, San Francisco Benioff Children's Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Individualized Caloric Refeeding (ICR)

Higher Calorie Refeeding (HCR)

Arm Description

Starting 50 kcal/kg/d, increasing by 200 kcal/d to goal

Starting 2000 kcal/d, increasing by 200 kcal/d to goal

Outcomes

Primary Outcome Measures

Time to Achieve Medical Stability in Hospital
Medical stability will be adjudicated by a five-point index: (1) 24 hour heart rate of 45 beats/min or more, (2) systolic blood pressure of 90 millimeters of mercury (mmHg) or more, (3) temperature of 35.6° C or more, (4) orthostatic increase in heart rate of 35 beats/min or less, (5) orthostatic change in systolic blood pressure of 20 mmHg or less.

Secondary Outcome Measures

Incidence of low serum electrolytes during refeeding in hospital
Incidence of low electrolytes will be defined as: (1) hypophosphatemia less than 3 milligrams per deciliter (mg/dL), (2) hypomagnesaemia less than 1.8 mg/dL, and (3) hypokalemia less than 3.5 milliequivalent per liter (mEq/L) during hospitalization.

Full Information

First Posted
July 8, 2021
Last Updated
April 3, 2023
Sponsor
University of California, San Francisco
Collaborators
Stanford University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
search

1. Study Identification

Unique Protocol Identification Number
NCT04966858
Brief Title
Individualized Study of Refeeding to Optimize iNpatient Gains
Acronym
i-STRONG
Official Title
Renewal of the Multi-center Randomized Controlled Trial of Refeeding in Anorexia Nervosa
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Enrolling by invitation
Study Start Date
October 28, 2021 (Actual)
Primary Completion Date
November 2024 (Anticipated)
Study Completion Date
April 14, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of California, San Francisco
Collaborators
Stanford University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The primary purpose of the trial is to compare the efficacy and safety of Individualized Caloric Refeeding (ICR) to the new standard of care, Higher Calorie Refeeding (HCR), in hospitalized patients with atypical anorexia nervosa (AAN), and clinical remission over one year of follow-up.
Detailed Description
Atypical Anorexia Nervosa (AAN) is a new diagnosis describing patients with malnutrition and significant weight loss yet "normal" weight. These patients responded poorly to HCR, the superior refeeding treatment in the parent trial, which was designed for low-weight patients with typical AN. The proposed trial will examine the safety and efficacy of a new treatment for AAN with the potential to improve treatment outcomes for this diverse and growing patient population. The major finding motivating the proposed trial is that participants with AAN gained weight 40 percent slower and required 3.0 additional days in hospital to restore medical stability on HCR, as compared to AN. The research team has developed Individualized Caloric Refeeding (ICR), which doses calories to weight consistent with other pediatric treatments (e.g. medication). The primary purpose of the proposed trial is to compare the efficacy and safety of ICR to the new standard of care (HCR) in hospitalized patients with AAN. The investigators hypothesize that ICR will restore medical stability faster than HCR with no increase in electrolyte abnormalities. After hospitalization, the major barrier to care in AAN is lack of consensus on clinical remission and whether these formerly overweight patients should gain weight to recover. The research team will examine metabolic, hormonal and psychological markers during long-term follow-up, toward the goal of developing a definition of clinical remission in AAN. Design Summary: Randomized controlled trial in N=74 participants age 12-24 with AAN, consented upon hospital admission, randomly assigned to ICR or HCR, followed daily in hospital and at 3, 6, 9 and 12 mo.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Atypical Anorexia Nervosa
Keywords
Malnutrition, Refeeding, Nutritional Rehabilitation, Adolescent Medicine

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Participants will be recruited upon hospital admission at the University of California, San Francisco (UCSF) and Stanford and randomly assigned to Individualized Caloric Refeeding (ICR) or Higher Calorie Refeeding (HCR) for the duration of the hospitalization. Treatment ends at hospital discharge with open follow-up for one year. Participants followed daily in hospital and at 3mo, 6mo, 9mo, and 12mo post-discharge.
Masking
None (Open Label)
Masking Description
Treatments are not to be blinded, since both the patients and clinicians who work with this population are highly skilled at estimating kcal and would be able to determine group assignment by simply viewing meal trays.
Allocation
Randomized
Enrollment
74 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Individualized Caloric Refeeding (ICR)
Arm Type
Experimental
Arm Description
Starting 50 kcal/kg/d, increasing by 200 kcal/d to goal
Arm Title
Higher Calorie Refeeding (HCR)
Arm Type
Active Comparator
Arm Description
Starting 2000 kcal/d, increasing by 200 kcal/d to goal
Intervention Type
Other
Intervention Name(s)
Individualized Caloric Refeeding (ICR)
Other Intervention Name(s)
ICR
Intervention Description
Meal-based refeeding in hospital, starting at 50 calories per kilogram of body weight, and increasing by 200 calories per day until caloric goal achieved
Intervention Type
Other
Intervention Name(s)
Higher Calorie Refeeding (HCR)
Other Intervention Name(s)
HCR
Intervention Description
Meal-based refeeding in hospital, starting at 2000 calories per day, and increasing by 200 calories per day until caloric goal achieved
Primary Outcome Measure Information:
Title
Time to Achieve Medical Stability in Hospital
Description
Medical stability will be adjudicated by a five-point index: (1) 24 hour heart rate of 45 beats/min or more, (2) systolic blood pressure of 90 millimeters of mercury (mmHg) or more, (3) temperature of 35.6° C or more, (4) orthostatic increase in heart rate of 35 beats/min or less, (5) orthostatic change in systolic blood pressure of 20 mmHg or less.
Time Frame
Inpatient hospitalization from day of admission to day of discharge, average 1-2 weeks
Secondary Outcome Measure Information:
Title
Incidence of low serum electrolytes during refeeding in hospital
Description
Incidence of low electrolytes will be defined as: (1) hypophosphatemia less than 3 milligrams per deciliter (mg/dL), (2) hypomagnesaemia less than 1.8 mg/dL, and (3) hypokalemia less than 3.5 milliequivalent per liter (mEq/L) during hospitalization.
Time Frame
Inpatient hospitalization from day of admission to day of discharge, average 1-2 weeks
Other Pre-specified Outcome Measures:
Title
Percentage median BMI (mBMI) Over 12 Months
Description
Measured BMI will be divided by the mBMI for age and sex per national growth data to give the percentage mBMI.
Time Frame
12 months post-study hospitalization
Title
Eating Disorder Examination Questionnaire (EDE-Q) Score Over 12 Months
Description
The EDE-Q will be self-administered; scores range from 1 to 6, with higher scores indicating greater severity and a worse outcome.
Time Frame
12 months post-study hospitalization

10. Eligibility

Sex
All
Minimum Age & Unit of Time
12 Years
Maximum Age & Unit of Time
24 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 12-24 yrs Meets Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for AAN Hospitalized with medical instability, as defined by: night time heart rate (HR) <45 bpm, systolic blood pressure (SBP) <90 mmHg, temperature <35.6° C, orthostatic Δ HR >35 bpm, or orthostatic Δ SBP >20 mmHg Exclusion Criteria: Bulimia nervosa Current pregnancy Chronic disease (e.g. immune, renal disease) Acute/active suicidality or psychosis Hospital admissions for refeeding in the prior 6 mo.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Andrea K Garber, RD, PhD
Organizational Affiliation
University of California, San Francisco
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Neville H Golden, MD
Organizational Affiliation
Stanford University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Stanford University Lucille Packard Children's Hospital
City
Palo Alto
State/Province
California
ZIP/Postal Code
94304
Country
United States
Facility Name
University of California, San Francisco Benioff Children's Hospital
City
San Francisco
State/Province
California
ZIP/Postal Code
94158
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Individualized Study of Refeeding to Optimize iNpatient Gains

We'll reach out to this number within 24 hrs